Fierce Pharma Week 2026: What Happens When Patient Support, Trust, and AI Converge? 

In mid-September, Cramer Health’s senior copywriter, Kristi Bray, attended Fierce Pharma Week in Philadelphia. Here is what the week looked like through her eyes, and what stayed with her.

Every conference has a theme that emerges long before anyone puts it on a slide. At Fierce Pharma Week 2026, that theme was trust.

Whether the conversation centered on patient support programs (PSPs), generative AI, patient engagement, field content, or storytelling, presenters kept returning to the same challenge: patients have more information than ever before, yet trust remains difficult to earn and easy to lose.

Here are the biggest ideas, trends, and opportunities that stood out to me from this year’s conference.

The Patient Support Problem Isn’t Enrollment. It’s Engagement.

One of the most striking statistics shared during the conference was that life sciences companies collectively invest billions in patient support programs, yet fewer than 10% of eligible patients enroll.

At first glance, that sounds like an enrollment problem. But several sessions suggested the reality is more nuanced.

If patients do not know support exists, they cannot use it. If they enroll only when they need access support and then disengage, programs will struggle to demonstrate long-term value. And if success is measured solely by enrollment rates, companies may miss the behaviors and outcomes that actually matter.

The takeaway was clear: a patient support program is only as effective as its outreach strategy.

Leading organizations are beginning to think beyond enrollment and ask bigger questions:

• Are patients aware of available services?
• Are they returning after enrollment?
• Are they engaging with educational resources?
• Are they staying on therapy longer?
• Are they taking meaningful actions that improve outcomes?

In other words, patients may come for access, but they stay for support.

That mindset shift creates new opportunities for targeted education, personalized communications, and ongoing engagement strategies that help patients long after the initial enrollment form is completed.

Trust Is the Competitive Advantage in the Age of AI

AI was impossible to escape this year.

Patients are increasingly using AI tools to interpret lab results, translate medical jargon, and supplement conversations with healthcare providers. Yet speaker after speaker noted an important distinction: patients use AI, but they do not necessarily trust it.

That distinction matters.

As one presenter observed, AI answers rarely end a patient’s search. People still verify information through Google deep dives, healthcare providers, caregivers, advocacy groups, and their peers.

For healthcare marketers, this changes the goal. Instead of competing against AI, pharma brands must become trustworthy sources that AI references and that patients feel confident validating against.

Several themes emerged repeatedly:

Truth and transparency build trust 

Patients want honest information, including the difficult parts. 

Pharma companies that openly discuss treatment realities, side effects, and limitations are often perceived as more credible than those that focus exclusively on positive outcomes. Avoiding challenges can inadvertently make patients feel unheard. 

Simplicity matters 

Patients are making treatment decisions in increasingly complex information environments. Clear, plain-language communication helps people understand difficult topics throughout the treatment journey, from disease and treatment education to navigating insurance and the healthcare system, as well as knowing what to expect during the specialty pharmacy process. 

Sessions emphasized starting with: 

• What it is 

• How it works 

• What it means 

Storytelling tools, including metaphors and narrative frameworks, can make complex information easier to understand without oversimplifying it. 

Human stories still win 

Across sessions, presenters warned against the rising wave of “AI slop,” content that feels generic, interchangeable, and disconnected from real experiences. 

The antidote is authenticity. 

Personal stories, emotional nuance, and lived experiences remain difficult for AI-generated content to replicate. Patients trust people more than platforms, and they trust experiences more than claims. 

The Patient Voice Is Bigger Than Testimonials

Several sessions challenged the industry’s traditional view of patient centricity.

One benchmarking discussion highlighted a sobering gap: while most life sciences organizations consider themselves patient-centric, only about 60% of patients agree.

Closing that gap requires more than publishing patient stories.

Speakers advocated for building insights directly from patient experiences through:

• Journey mapping
• Market research
• Support program interactions
• Patient services call-center data
• Caregiver feedback

In fact, some of the most valuable insights may come from outliers rather than averages.

One comment that resonated throughout the conference was:

“The outlier insights become the authentic stories.”

Organizations that actively listen to patients often uncover barriers that seem small internally but create significant friction in the real world.

One example discussed was a medication delivery process that required signatures upon receipt. Patients were not always aware of the requirement, leading to missed deliveries and frustration. Removing that barrier improved the patient experience and increased satisfaction.

The lesson: trust is often won or lost in operational details, not just marketing messages.

GEO and Conversational AI Are Creating New Opportunities

If AI was the dominant conversation, Generative Engine Optimization (GEO) was not far behind.

Multiple speakers noted that patients are increasingly asking questions directly to AI tools rather than searching through traditional websites.

This trend creates both risk and opportunity.

Organizations that fail to optimize content for AI discovery risk allowing misinformation to fill the gap. Organizations that succeed can become trusted sources in emerging AI ecosystems.

Several presenters discussed conversational AI experiences embedded directly into brand websites, allowing patients and healthcare providers to find information faster from approved content.

Beyond improving the user experience, these tools provide valuable insights into:

• How patients phrase questions
• What information is difficult to find
• What content gaps exist
• Which topics generate the most interest

For marketers, that feedback loop may be just as valuable as the technology itself.

What Caught My Eye Outside the Sessions 

As always, Fierce Pharma Week offered plenty of inspiration beyond the keynote stage. 

Conference experiences continued to become more immersive, reflecting a broader trend toward memorable, sensory-driven engagement. 

This year’s most popular booth experiences included: 

• Italian-inspired treats like gelato, cannoli, espresso, and Italian soda 

• Custom hat stations 

• Pancake artists 

• Aroma-focused activations blending beverages and scent experiences 

• Stuffed animals 

• Returning favorites like puppy parks, smoothie bars, golf simulators, and oxygen bars